ARAY
Accuray Incorporated
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Best Medical Devices Stocks 2026 →
Accuray (ARAY) Stock: Buy, Sell, or Hold?
$2.80
-0.28 (-9.09%)
▼
5d:
+2445.45%
30d:
+1511.05%
90d:
+757.32%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 04, 2026
0d
Protect ARAY Gains
Updated Nov 13, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (5%)
Quality Score
31/100
Position
EXTENDED
30-Day Fair Range
$-0.47 – $1.89
Position: EXTENDED
Forward P/E & Valuation
-9.3x
CHEAP
vs 39.3x historical avg
Wall Street Target
$0.35
-87.5% vs target
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.11 / $4.05
Trend: Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR BETTER ENTRY: ARAY is 48.1% above its trading range ($1.89). Market expects 0% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
Get Alerted When ARAY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: ARAY is currently trading at $2.80, which is considered extended relative to its 30-day fair value range of $-0.47 to $1.89. From a valuation perspective, the stock is trading at a discount (Forward PE: -9.3) compared to its historical average (39.3). At these levels, the market is pricing in 0% annual earnings growth.
Technical Outlook: Technically, ARAY is in a uptrend. Immediate support is located at $0.11, while resistance sits at $4.05. Short-term momentum is weak, with the stock down 9.1% recently.
Market Sentiment: ARAY scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $0.35. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ARAY is in a uptrend. Immediate support is located at $0.11, while resistance sits at $4.05. Short-term momentum is weak, with the stock down 9.1% recently.
Market Sentiment: ARAY scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $0.35. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$-0.47 -
$1.89
Company Quality Score
31/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
4.8%
Trading Range & Key Levels
30-Day Trading Range
$-0.47 -
$1.89
Current vs Trading Range
EXTENDED
Support Level
$0.11
Resistance Level
$4.05
Current Trend
Uptrend
Technical data as of
Nov 13, 2026
Protect Your Profits
ARAY is technically overbought (RSI 74). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanQuantitative Signal Breakdown
- BEARISH: Price significantly overextended (+48.1% above its trading range)
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-9.1%)
- BEARISH: Trading 87.5% above Wall St target ($0.35)
- WARNING: Composite score 31/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-9.33
Wall Street Target
$0.35
(-87.5%)
Revenue Growth (YoY)
-7.9%
Earnings Growth (YoY)
-96.2%
Profit Margin
-4.4%
PE vs Historical
-9.3 vs 39.3
CHEAP
Share ARAY Analysis
Share this live ARAY analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (ARAY)
Bearish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 12, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits shows bullish sentiment towards $ARAY with one user predicting double-digit gains. No newsworthy articles available.
Key Retail Themes:
Bullish outlook
Anticipation of price increase
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 15, 2026 4:24 AM ET
Data refreshes hourly during market hours. Next update: 5:24 AM
Data refreshes hourly during market hours. Next update: 5:24 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ARAY showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$98 | 59 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
28 analysts |
$119 | 49 HOLD |
|
SYK
Stryker Corporation |
STRONG BUY
30 analysts |
$340 | 37 SELL |
|
EW
Edwards Lifesciences Corp |
STRONG BUY
30 analysts |
$112 | 33 SELL |
|
BSX
Boston Scientific Corp |
BUY
31 analysts |
$50 | 48 HOLD |
Advanced ARAY Option Strategies
Professional options setups generated by AI based on today's ARAY price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive ARAY Research Pages
